![glp-1 agonist history Discovery of GLP-1–Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]](https://www.nejm.org/cms/10.1056/NEJMcibr2409089/asset/1f854e14-bfd6-40e1-8b1c-03461c2a1ab4/assets/images/large/nejmcibr2409089_f1.jpg)
glp-1 agonist history Discovery of GLP-1–Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]
Description
What do clinical trials actually show for T1D
![glp-1 agonist history Discovery of GLP-1Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
(February 2022)
![glp-1 agonist history Discovery of GLP-1Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/369591229/figure/fig4/AS:11431281195892323@1696470506568/Timeline-of-GLP-1-discovery-and-clinical-development-a-Key-events-in-the-discovery-and.png)
doi: 10.1038/ki.2009.322
![glp-1 agonist history Discovery of GLP-1Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig1_HTML.png)
GIP is produced by enteroendocrine K cells ( The biologically active GIP(1-42) is short-lived (half-life of 7 minutes) ( Figure 1 )
![glp-1 agonist history Discovery of GLP-1Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]](https://mendinground.com/wp-content/uploads/2025/06/GLP-1-medications-1024x791.png)
Zhang XY, Yu L, Wang K, Wang M, Li P, Zheng ZG, et al
![glp-1 agonist history Discovery of GLP-1Based Drugs for the Treatment of Obesity glp-1_analogs [TUSOM | Pharmwiki]](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3863453287363198128)
